Cart
sales@molnova.com
AG 99
CAS No. 122520-85-8
AG 99( (E)-Tyrphostin AG 99 | (E)-Tyrphostin 46 | Tyrphostin 46 )
Catalog No. M19940 CAS No. 122520-85-8
AG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 27 | In Stock |
|
| 10MG | 42 | In Stock |
|
| 25MG | 66 | In Stock |
|
| 50MG | 87 | In Stock |
|
| 100MG | 147 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG 99
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
-
DescriptionAG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
-
In Vitro(E)-AG 99 effectively blocks tyrosine phosphorylation of p145met and promotes cell death accompanied by activation of caspase-like proteases.
-
In Vivo——
-
Synonyms(E)-Tyrphostin AG 99 | (E)-Tyrphostin 46 | Tyrphostin 46
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number122520-85-8
-
Formula Weight204.18
-
Molecular FormulaC10H8N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20 mg/mL;Ethanol: 1 mg/mL;Water: Insoluble
-
SMILESNC(=O)C(=C\c1ccc(O)c(O)c1)\C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gazit A et al. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro. J Med Chem. 1996 Dec 6;39(25):4905-11.
molnova catalog
related products
-
DBPR112
DBPR112 is an orally active furanopyrimidine-based EGFR inhibitor with IC50s of 15 nM for EGFRWT and 48 nM for EGFRL858R/T790M, capable of occupying the ATP-binding site and demonstrating significant antitumor efficacy.
-
Nimotuzumab
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
-
JND3229
JND3229 is a reversible EGFRC797S inhibitor with IC50 values of 5.8, 6.8 and 30.5 nM for EGFRL858R/T790M/C797S, EGFRWT and EGFRL858R/T790M, respectively.
